Lebeau, G.; Frumence, E.; Turpin, J.; Begue, F.; Hoarau, J.-J.; Gadea, G.; Krejbich-Trotot, P.; Desprès, P.; Viranaicken, W.
Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development. Vaccines 2021, 9, 283.
https://doi.org/10.3390/vaccines9030283
AMA Style
Lebeau G, Frumence E, Turpin J, Begue F, Hoarau J-J, Gadea G, Krejbich-Trotot P, Desprès P, Viranaicken W.
Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development. Vaccines. 2021; 9(3):283.
https://doi.org/10.3390/vaccines9030283
Chicago/Turabian Style
Lebeau, Grégorie, Etienne Frumence, Jonathan Turpin, Floran Begue, Jean-Jacques Hoarau, Gilles Gadea, Pascale Krejbich-Trotot, Philippe Desprès, and Wildriss Viranaicken.
2021. "Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development" Vaccines 9, no. 3: 283.
https://doi.org/10.3390/vaccines9030283
APA Style
Lebeau, G., Frumence, E., Turpin, J., Begue, F., Hoarau, J.-J., Gadea, G., Krejbich-Trotot, P., Desprès, P., & Viranaicken, W.
(2021). Zika E Glycan Loop Region and Guillain–Barré Syndrome-Related Proteins: A Possible Molecular Mimicry to Be Taken in Account for Vaccine Development. Vaccines, 9(3), 283.
https://doi.org/10.3390/vaccines9030283